9.15
price down icon1.08%   -0.10
after-market After Hours: 9.15
loading
Elicio Therapeutics Inc stock is traded at $9.15, with a volume of 147.23K. It is down -1.08% in the last 24 hours and down -17.12% over the past month. Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.
See More
Previous Close:
$9.25
Open:
$9.27
24h Volume:
147.23K
Relative Volume:
1.41
Market Cap:
$149.50M
Revenue:
-
Net Income/Loss:
$-33.82M
P/E Ratio:
-0.3576
EPS:
-25.5891
Net Cash Flow:
$-66.04M
1W Performance:
-6.06%
1M Performance:
-17.12%
6M Performance:
+66.36%
1Y Performance:
+98.48%
1-Day Range:
Value
$9.07
$9.60
1-Week Range:
Value
$9.00
$9.81
52-Week Range:
Value
$4.60
$12.62

Elicio Therapeutics Inc Stock (ELTX) Company Profile

Name
Name
Elicio Therapeutics Inc
Name
Phone
(857) 209-0050
Name
Address
451 D STREET, 5TH FLOOR, BOSTON
Name
Employee
26
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
ELTX's Discussions on Twitter

Compare ELTX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ELTX
Elicio Therapeutics Inc
9.15 151.13M 0 -33.82M -66.04M -25.59
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
421.67 109.22B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
628.00 67.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
423.47 57.35B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
831.48 50.87B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
182.77 39.72B 447.02M -1.18B -906.14M -6.1812

Elicio Therapeutics Inc Stock (ELTX) Latest News

pulisher
07:08 AM

How Elicio Therapeutics Inc. (9HA) stock reacts to new regulationsJuly 2025 Update & Technical Buy Zone Confirmation - newser.com

07:08 AM
pulisher
06:47 AM

How high can Elicio Therapeutics Inc. stock goEarnings Recap Report & Smart Money Movement Tracker - newser.com

06:47 AM
pulisher
04:39 AM

Can Elicio Therapeutics Inc. stock outperform in 2025 bull market2025 Volatility Report & Daily Profit Maximizing Tips - newser.com

04:39 AM
pulisher
04:26 AM

Will Elicio Therapeutics Inc. outperform the marketMarket Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com

04:26 AM
pulisher
02:11 AM

Using economic indicators to assess Elicio Therapeutics Inc. potentialJuly 2025 Market Mood & Low Drawdown Investment Strategies - newser.com

02:11 AM
pulisher
12:25 PM

Elicio Therapeutics Inc. stock trendline breakdown2025 Trade Ideas & AI Powered Market Entry Strategies - newser.com

12:25 PM
pulisher
Nov 03, 2025

Analyzing net buyer seller activity in Elicio Therapeutics Inc.Weekly Trading Summary & Safe Entry Momentum Stock Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Analyzing drawdowns of Elicio Therapeutics Inc. with statistical toolsWeekly Stock Report & High Return Trade Guides - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Statistical indicators supporting Elicio Therapeutics Inc.’s strengthJuly 2025 News Drivers & Expert Approved Momentum Trade Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How Elicio Therapeutics Inc. (9HA) stock moves in volatile trading sessionsMarket Sentiment Report & Daily Volume Surge Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Elicio (NASDAQ: ELTX) to present late-breaking Phase 2 ELI-002 data at SITC 2025 - Stock Titan

Nov 03, 2025
pulisher
Nov 03, 2025

Key metrics from Elicio Therapeutics Inc.’s quarterly dataMarket Rally & Low Drawdown Investment Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Elicio Therapeutics Inc. stock oversold or undervalued2025 Volatility Report & Growth Focused Entry Point Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Elicio Therapeutics Inc. (9HA) stock bottoming after sell offBull Run & Expert-Curated Trade Recommendations - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What valuation multiples suggest for Elicio Therapeutics Inc. stockMarket Volume Report & Safe Swing Trade Setups - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Can Elicio Therapeutics Inc. (9HA) stock attract ESG investmentsEarnings Overview Summary & Low Drawdown Momentum Trade Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Can Elicio Therapeutics Inc. stock weather global recessionQuarterly Profit Report & Daily Entry Point Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Elicio Therapeutics Inc. stock attractive for hedge funds2025 Support & Resistance & Free Safe Capital Growth Stock Tips - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

How Elicio Therapeutics Inc. stock compares to market leadersEarnings Overview Report & Fast Momentum Stock Entry Tips - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Elicio Therapeutics, Inc. (ELTX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Nov 01, 2025
pulisher
Nov 01, 2025

What earnings revisions data tells us about Elicio Therapeutics Inc.Weekly Gains Report & Capital Efficient Trade Techniques - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Is Elicio Therapeutics Inc. stock poised for growthFed Meeting & Risk Managed Investment Entry Signals - newser.com

Oct 31, 2025

Elicio Therapeutics Inc Stock (ELTX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.84
price up icon 1.45%
$28.76
price up icon 0.17%
$102.92
price up icon 1.33%
$104.83
price up icon 0.84%
biotechnology ONC
$309.19
price down icon 0.86%
$182.77
price down icon 1.86%
Cap:     |  Volume (24h):